loading animation for AJAX calls

181 Reports in Pharmaceuticals

Lysosomal Disease Treatments: Technologies and Global Markets

Published - Oct 2018 | Publisher - BCC Publishing| Code - PHM183A

The global market for lysosomal storage diseases treatment should grow from $5.1 billion in 2018 to reach $7.6 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.

Global Markets for Treatment and Diagnosis of Sexually Transmitte...

Published - Sep 2018 | Publisher - BCC Publishing| Code - PHM005D

The global market for sexually transmitted disease therapeutics reached $52.0 billion in 2018 and should reach nearly $63.0 billion by 2023, at a compound annual growth rate (CAGR) of 3.9% for the period of 2018-2023.

Antiemetics: Technologies and Global Markets

Published - Aug 2018 | Publisher - BCC Publishing| Code - PHM070B

The global market for antiemetics reached $4.1 billion in 2017 and should reach $5.9 billion by 2022, at a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2018-2023.

Pharmaceuticals for Women's Health: Global Markets to 2023

Published - Aug 2018 | Publisher - BCC Publishing| Code - PHM203A

The global market for women’s health therapeutics reached nearly $30.5 billion in 2018 and should reach nearly $37.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.2% for the period of 2018-2023. 

Cognition and Memory Enhancement Drugs: Technologies and Global M...

Published - Jul 2018 | Publisher - BCC Publishing| Code - PHM184A

The global cognition and memory-enhancing drugs market should reach over $4.2 billion by 2022 from $2.8 billion in 2017 at a compound annual growth rate (CAGR) of 8.7% for the period 2017-2022.

Active Pharmaceutical Ingredients: Global Markets to 2022

Published - Jul 2018 | Publisher - BCC Publishing| Code - PHM200A

The global active pharmaceutical ingredient (API) market should reach $154.7 billion by 2022 from $114.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.2% for the period 2017-2022.

Neuroprotective Agents: Therapeutic Applications and Global Marke...

Published - Jul 2018 | Publisher - BCC Publishing| Code - PHM188A

The global market for neuroprotective agents will grow from $54.4 billion in 2017 to $75.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.8% for the period of 2017-2022.

Antiulcerant Drugs: Global Markets to 2022

Published - Jun 2018 | Publisher - BCC Publishing| Code - PHM202A

The global antiulcerant drugs market will grow from $33.0 billion in 2017 to $37.4 billion by 2022 with a compound annual growth rate (CAGR) of 2.5% for the period of 2017-2022.

Clinical Nutrition: Global Markets to 2022

Published - May 2018 | Publisher - BCC Publishing| Code - PHM198A

The global clinical nutrition market should reach $60.8 billion by 2022 from $48.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.8% for the period 2017-2022.

The Global Influenza Market

Published - May 2018 | Publisher - BCC Publishing| Code - PHM049E

The global influenza market was valued at nearly $5.6 billion in 2017 and is expected to reach nearly $6.5 billion by 2022, increasing at a compound annual growth rate (CAGR) of 3.0% from 2017 through 2022.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...

Published - May 2018 | Publisher - BCC Publishing| Code - PHM153B

The global market for circulating tumor cell technology will grow from nearly $4.6 billion in 2017 to around $10.3 billion by 2022 with a compound annual growth rate (CAGR) of 17.6% for the period of 2017-2022.

Excipients in Pharmaceuticals: Global Markets to 2022

Published - May 2018 | Publisher - BCC Publishing| Code - PHM010K

The global market for pharmaceutical excipients will grow from nearly $6.8 billion in 2017 to $8.7 billion by 2022 with a compound annual growth rate (CAGR) of 4.9% for the period of 2017-2022.

Drugs for Urinary Incontinence and Overactive Bladder: Global Mar...

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM199A

The global drugs for urinary incontinence and overactive bladder market should reach $4.2 billion by 2022 from $3.6 billion in 2017 at a compound annual growth rate (CAGR) of 2.9%, from 2017 to 2022.

Muscle Relaxants: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM196A

The global muscle relaxants market totaled $18.4 billion in 2017 and is estimated to reach $24.4 billion by 2022, growing at a compound annual growth rate (CAGR) of 5.8% for the period of 2017-2022. 

Anti-Epileptic Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM197A

The global anti-epileptic drugs market totaled $8.4 billion in 2017 and is estimated to reach $9.5 billion by 2022, growing at a compound annual growth rate (CAGR) of 2.7% for the period of 2017-2022.

Drugs for Infertility: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM194A

The global market for drugs for infertility should reach $4.2 billion by 2022 from $3.4 billion in 2017 at a compound annual growth rate (CAGR) of 4.3%, from 2017 to 2022.

Global Markets for Vaccine Technologies

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM014G

The global market for vaccine technologies reached $35.7 billion in 2017 and should reach nearly $46.6 billion by 2022, at a compound annual growth rate (CAGR) of 5.5% for the period of 2017-2022.

Cardiovascular Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM191A

The global cardiovascular drugs market should reach $149.4 billion by 2022 from $141.1 billion in 2017 at a compound annual growth rate (CAGR) of 1.2%, from 2017 to 2022.

Small Molecule Therapies for Rheumatoid Arthritis: Global Markets...

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM195A

The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM043G

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $136.4 billion in 2017 to $197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Anti-Parkinson's Drugs: Global Markets to 2022

Published - Apr 2018 | Publisher - BCC Publishing| Code - PHM193A

The global anti-Parkinson’s drugs market should reach $5.7 billion by 2022 from $4.2 billion in 2017 at a compound annual growth rate (CAGR) of 6.1% from 2017 to 2022.

Global Markets for Infectious Disease Treatments

Published - Mar 2018 | Publisher - BCC Publishing| Code - PHM061D

The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.

Global Cancer Therapeutics Market: Emphasis on Recurrent and Meta...

Published - Dec 2017 | Publisher - BCC Publishing| Code - PHM177A

The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.

Medication Adherence: Systems, Technologies and Global Markets

Published - Nov 2017 | Publisher - BCC Publishing| Code - PHM182A

The global market for medication adherence reached $1.7 billion in 2016 and should reach nearly $4.0 billion by 2021 at a compound annual growth rate (CAGR) of 18.0% from 2016 through 2021.

Substance Abuse and Addiction Treatment, Global Markets to 2021

Published - Aug 2017 | Publisher - BCC Publishing| Code - PHM035C

The global substance abuse and addiction treatment market reached $3.1 billion in 2016 and should reach nearly $4.4 billion in 2021, at a compound annual growth rate (CAGR) of 7.0%.

« 1 2 3 4 5 »

1 Upcoming Reports in Pharmaceuticals

Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Target Date - Sep 2019| Publisher - BCC Publishing | Code - PHM220A| Price - $5,500
Report Includes
  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM